Increasing prevalence of chronic diseases such as cancer and diabetes and favorable government policies for the pharmaceutical sector are the major factors driving the growth of Indian peptides market.
The Indian Peptides and Heparin Market worth 883.0 Million and 170.2 Million USD by 2022, respectively
MarketsandMarkets™ - Sep 15, 2017
